Target RWE’s Post

We're very excited about ISPE 2024! We have research on #COVID, #RealWorldData, and #CausalInference and more for you to see. Take a look and see what you might not want to miss 👉🏼 https://ow.ly/HBgt50SNx30 #ISPEAnnual2024 #Pharmacoepidemiology International Society for Pharmacoepidemiology

Next week at #ISPEAnnual2024, join Aetion’s Co-Founder and President Jeremy Rassen for the pre-conference skills course, “Propensity Scores in Pharmacoepidemiology,” where he and co-presenter Dr. John Seeger will explain how propensity scores can be used to mitigate confounding through standard observational approaches. #pharmacoepidemiology #icpe

Going to #ISPE? Stop by Joseph Zabinski, Ph.D.'s presentation on August 26 from 12-1230pm CEST to learn how OM1, Inc. capabilities can help advance your clinical work

#Rwtdttt package released today - the parametric Waiting Time Distribution has come to R! 🎉 After a year of hard work together with a great team (Malcolm Gillies, Sabrina Giometto and Olga Paoletti), I am so proud and delighted to share the package with all of you R users, and I hope it will allow many more to use the parametric Waiting Time Distribution for estimation of prescription lengths in #pharmacoepidemiology. You will find the package for free download and use at github here: https://lnkd.in/eSDNgnvF You will probably want to start by reading the README.md file for instructions on how to install the procedure in R. In comments to this post I will share some notes on the release and provide references if you want to know more about the method and its use. Here though I will end by sharing a picture of the proud parents of the projects at our informal online release party this morning :-)

Gaps in data are a common problem in #realworlddata sources. Key variables may only be found in unstructured #clinicalnotes or missing entirely from the electronic medical records (#EMR). Join Joseph Zabinski, Ph.D. at #ISPEAnnual2024 to learn about novel approaches of #AI-based methods to address data gaps in #RWD. International Society for Pharmacoepidemiology #AIHealth #RWE #Pharmacoepidemiology

Let's meet at #ICPE in Berlin next month! Our #RWD and scientific experts including Jeff Brown and Arnold Chan will be available to discuss how we can help you find clinical solutions for your needs. Meet with us: https://ow.ly/VUxZ30sFloU #Pharmacoepidemiology #RealWorldData #epidemiology

For our dear client Dr. Willmar Schwabe we conducted and published a study about real world effectiveness of Hawthorn special extract WS 1442. In the present study, we investigated antiarrhythmic effects of WS 1442 compared with magnesium/potassium in a large collective of outpatients using the IQVIA Disease Analyzer (DA) database. This study showed that in intake of hawthorn special extract WS 1442 was associated with a significantly lower #incidence of #atrial #fibrillation, #tachycardia, and other #cardiac #arrhythmias compared to #magnesium/#potassium, indicating its potential in treating and preventing such conditions. IQVIA Germany #epidemiology #phytopharmaceutical #cardiology #medical_affairs

GLP-1 receptor agonist drugs, originally intended for diabetes treatment, have experienced a substantial increase in usage for weight loss in recent times. However, a recent study has raised concerns about their potential risks. The study found that the use of GLP-1 RA for 1–3 years was associated with an elevated risk of all thyroid cancer (adjusted hazard ratio [HR] 1.58, 95% CI 1.27–1.95) and medullary thyroid cancer (adjusted HR 1.78, 95% CI 1.04–3.05). These findings underscore the importance of carefully considering the potential consequences of prolonged GLP-1 RA use beyond their established benefits for diabetes management. #DiabetesManagement #GLP1RA #HealthResearch #WeightLoss #ThyroidCancer #HealthcareAwareness #MedicationSafety #Endocrinology #HealthConcerns #Epidemiology #Meddata Read more about it here: https://lnkd.in/eW26nXiE

🔔 Special Issue Announcement! Recent Advances in the Pharmacoepidemiology of Antirheumatic Medication Stay up to date with the current and shifting trends in the field of pharmacoepidemiology of antirheumatic medications. This Special Issue is now accepting a wide range of contributions, including original research articles, systematic and narrative review articles, commentaries, letters, and other materials that facilitate a deeper understanding of this fundamental topic. For more information and submission guidelines, please visit: https://lnkd.in/dsE-PWzv #Pharmacoepidemiology #AntirheumaticMedication

Explore the latest research on rescue therapy for supratherapeutic concentrations of calcineurin inhibitors using potent cytochrome P450 inducers. Rescue Therapy for Supratherapeutic Concentrations of Calcineurin Inhibitors Using Potent Cytochrome P450 Inducers Read the full article: https://lnkd.in/d_ew4hu3 #CalcineurinInhibitors #CytochromeP450 #DrugTherapy #pharmacoepidemiology